SecBot SecBot
3 ·Filed Nov 5, 2026

DGX

QUEST DIAGNOSTICS INC
NEUTRAL
Impact 2/10
Horizonimmediate Processed11d 2h ago SEC0001022079-26-000120
Form 3: initial insider ownership statement
Actionable Insight • Neutral

This is a routine insider onboarding filing with no trading signal. Monitor future Form 4 filings for any open-market purchases or sales by the new SVP.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$255.63
T+0 close · Nov 5, 2026 · via day close
Latest settled
+1.55%
T+5 · $259.60
Vs SPY
−1.04%
α at T+5
Next horizon
T+20
in 20d
  1. T+0 · Nov 6 $255.63entry
  2. T+1 · 8d ago +1.58%α −0.79% · $259.67
  3. T+5 · 4d ago +1.55%α −1.04% · $259.60
  4. T+6 · todayOpen
  5. T+20 · in 20d Pending
  6. T+60 · in 3mo Pending

Price Chart

Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Subu Ramachandran filed a Form 3 initial statement of beneficial ownership upon becoming an insider (SVP, Regional Businesses) at Quest Diagnostics. The filing discloses 2,480 shares of common stock and 12,048 exercisable stock options with strike prices ranging from $112.17 to $204.96, expiring between 2030 and 2036. This is a routine insider onboarding filing with no material impact on the company's financials or operations.

Key Facts

  • Subu Ramachandran appointed SVP, Regional Businesses at Quest Diagnostics
  • Form 3 filed on 2026-11-05, reporting period 2026-11-01
  • Discloses 2,480 shares of common stock owned directly
  • Discloses 12,048 non-qualified stock options exercisable across 6 tranches with strike prices from $112.17 to $204.96
  • Options vest in three equal annual installments beginning on first anniversary of grant date

Financial Impact

No financial impact; insider holds 2,480 shares and options representing approximately 0.01% of shares outstanding

Risk Factors

  • No material risks identified from this filing

Market Snapshot

Exchange
NYSE
Sector
Services-Medical Laboratories
Analyst Consensus
52% bullish (23 analysts)

Investment Themes

Healthcare & Medical Devices

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
3 Filing (Primary)0001022079-26-000120
Document: 0001022079-26-000120-index-headers.html0001022079-26-000120
Document: 0001022079-26-000120-index.html0001022079-26-000120
Document: 0001022079-26-000120.txt0001022079-26-000120

Track record

24 reports on DGX

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
  2. Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
  3. Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
  4. Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
  5. Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  6. Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
  7. Nov 5, 202611d ago 3 Neutral 2/10 Viewing Entry $255.63 Now $262.21 +2.57% settles Feb 4
  8. Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  9. Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
  10. Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
Showing 10 of 24

US Market Status

Market Closed · Opens Wed (11h 54m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 5, 2026